MICRORNAS EXPRESSION IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE

被引:0
|
作者
Fallah, Parviz [1 ]
Zamanizadeh, Ayeh [2 ]
Obeidi, Narges [3 ]
机构
[1] Alborz Univ Med Sci, Sch Para Med, Karaj, Iran
[2] Razi Pathobiol Lab, Karaj, Iran
[3] Bushehr Univ Med Sci, Sch Para Med, Depart Dept Hematol, Bushehr, Iran
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:37 / 37
页数:1
相关论文
共 50 条
  • [21] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Wang, Jianxiang
    Kim, Dong-Wook
    Kim, Dennis Dong Hwan
    Mayer, Jiri
    Goh, Yeow-Tee
    le Coutre, Philipp
    Takahashi, Naoto
    Kim, Inho
    Etienne, Gabriel
    Andorsky, David
    Issa, Ghayas C.
    Larson, Richard A.
    Bombaci, Felice
    Kapoor, Shruti
    McCulloch, Tracey
    Malek, Kamel
    Yau, Lillian
    Ifrah, Sophie
    Hoch, Matthias
    Cortes, Jorge E.
    Hughes, Timothy P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [22] Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
    Kantarjian, Hagop
    Shah, Neil P.
    Hochhaus, Andreas
    Cortes, Jorge
    Shah, Sandip
    Ayala, Manuel
    Moiraghi, Beatriz
    Shen, Zhixiang
    Mayer, Jiri
    Pasquini, Ricardo
    Nakamae, Hirohisa
    Huguet, Francoise
    Boque, Concepcion
    Chuah, Charles
    Bleickardt, Eric
    Bradley-Garelik, M. Brigid
    Zhu, Chao
    Szatrowski, Ted
    Shapiro, David
    Baccarani, Michele
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24): : 2260 - 2270
  • [23] Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase
    Deotare, Uday
    Kim, Dennis Dong Hwan
    Lipton, Jeffrey H.
    DRUGS & AGING, 2016, 33 (05) : 335 - 345
  • [24] Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase
    Uday Deotare
    Dennis Dong Hwan Kim
    Jeffrey H. Lipton
    Drugs & Aging, 2016, 33 : 335 - 345
  • [25] Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia
    Garrett, May
    Knight, Beverly
    Cortes, Jorge E.
    Deininger, Michael W.
    CANCER MEDICINE, 2023, 12 (17): : 17981 - 17992
  • [26] Efficacy and Safety of Generic Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Multicenter in China
    Yu, Wenjuan
    Du, Xin
    Wang, Weiguang
    Lou, Jin
    Liu, Peng
    Meng, Li
    Jin, Jie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (09): : E867 - E873
  • [27] Clinical characteristics,treatment pattern,and outcomes in newly diagnosed patients with chronic myeloid leukemia in the chronic phase by age
    彭楠
    ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (02) : 120 - 120
  • [28] Management of patients with newly diagnosed chronic myeloid leukemia: Opportunities and challenges
    Jabbour, Elias
    Cortes, Jorge
    O'Brien, Susan
    Rios, Mary Beth
    Giles, Francis
    Kantarjian, Hagop
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S51 - S57
  • [29] IMATINIB MESYLATE IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Iordache, M.
    Cheveresan, L.
    Ionita, M.
    Borzak, G.
    Ionita, C. O.
    Pascalau, A.
    Calamar, D.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 548 - 548
  • [30] Techniques for risk stratification of newly diagnosed patients with chronic myeloid leukemia
    Mitchell, Birgitta
    Deininger, Michael
    LEUKEMIA & LYMPHOMA, 2011, 52 : 4 - 11